| |
Current Study:
YOUNG CHILDREN WITH AUTISM AND PDD
Jaswinder Ghuman, M.D. and her research team are conducting a study to evaluate the effects of medicine, methylphenidate, to treat problems with hyperactivity, impulsiveness and distractibility in 3-6 year old children with autism or Pervasive Developmental Disorders (PDD).
Download Windows Video on Autism Research (.wmv)
Who can participate?
Boys and girls:
- ages 3-6 years
- diagnosed or suspected to have autism/PDD or have problems with social interaction and development
- also have problems with hyperactivity, impulsiveness and distractibility for at least 6 months
- currently attending an early intervention program, a behavior program, preschool or school
Why participate?
- Free evaluation and treatment for the child
- Help increase understanding of hyperactivity, impulsiveness and distractibility problems in children with autism and PDD
- Help other individuals/families living with children with autism and PDD
Target symptoms for methylphenidate treatment include:
- Hyperactivity
- Constant fidgeting, squirming
- Always “on the go”
- Not waiting his/her turn
- Interrupting
- Impulsivity
- Easily distracted
What’s Involved?
- FREE evaluation: A child psychiatrist and other members of the research team will evaluate the child (with parent and teacher input) to determine if your child has autism/PDD and problems with hyperactivity, impulsiveness and distractibility
- Evaluation to see if child needs medication
- FREE medication
- Physician monitoring of medication (using information from teachers and weekly visits with patient, parent) at NO COST TO THE CAREGIVERS
For More Information Call:
Dr. Jaswinder Ghuman
(520) 626-6473
The University of Arizona
Department of Psychiatry
1501 N. Campbell Ave.
Tucson, AZ 85724-5002
|
|
|
